In conclusion, MIR503HG expression was downregulated in ovarian tumor tissues and cells, and MIR503HG overexpression impaired the proliferative, invasive and EMT properties, and facilitated cell apoptosis in ovarian cancer cells. Here, MIR503HG is linked to ovarian carcinoma.